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SUPPLEMENTARY NOTES
ABSTRACT
Chronic peripheral inflammation and neuroinflammation have been linked to Gulf War Illness (GWI), but the underlying mechanisms are unknown. A Multiple-Hit Hypothesis is supported, where the synergistic interaction of several potential neurotoxicants and triggers of inflammation, such as persistent peripheral inflammation and the organophosphate pesticide chlorpyrifos (CPF) may interact to culminate in diverse symptoms. As a consequence of this biological and chemical complexity, early/accurate diagnosis and effective treatments have proven elusive. Our research over the last year has addressed these issues in GWI with a "Multiple-Hit" mouse model of GWI-like exposures and focused on the key molecular target NF-κB p50 in CNS effects. Experiments employing a mouse model of GWI for short term and long term analysis of the brain after GWI-like exposures have been completed for AIM1 along with the collection of circulating white blood cells for AIM3. While sample analysis is ongoing, preliminary results suggest that the hippocampus in NF-κB p50-/-mice is more vulnerable to chronic neuroinflammation at one week after pro-inflammatory insult. We also report that CPF impairs NF-κB p50 function in microglia, suggesting that CPF may predispose the hippocampus to chronic neuroinflammation. We will directly test this hypothesis as the collected samples are further analyzed.
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Introduction
Chronic peripheral inflammation and neuroinflammation have been linked to Gulf War Illness (GWI), but at present there is little information regarding the underlying mechanisms of this multifaceted illness. Current opinion supports a Multiple-Hit Hypothesis, where the synergistic interaction of several potential neurotoxicants and triggers of inflammation, such as persistent infections, and the organophosphate pesticide chlorpyrifos (CPF) may interact to culminate in diverse symptoms. As a consequence of this biological and chemical complexity, early/accurate diagnosis and effective treatments have proven elusive. This research proposal begins to address these issues in GWI using an in vivo approach with a "Multiple-Hit" model of Gulf War exposures that focuses on the key molecular target, NF-κB p50 in the brain. NF-κB is a redoxsensitive, prototypical pro-inflammatory transcription factor family associated with inflammationmediated CNS pathology. Our recent work has shown that oxidized NF-κB p50 is linked to loss of function and a CNS-specific vulnerability to chronic inflammation. Interestingly, we have also shown that the GW exposure CPF oxidizes NF-κB p50 in the brain's innate immune cell, microglia. The first year of this research was dedicated to AIM1 to discern the role of NF-κB p50 in the early and late CNS effects present in our multiple hit mouse model of GWI.
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Accomplishments
Accomplishments are the same as the last report due to unusual transfer of the award to the new institution. Research was halted for an entire year, where YEAR 2 will commence on November 1, 2015.
I. Relevant Major Project Goals
Objectives per the Statement of Work
Research will be restricted to the following objectives: 1) assessing mechanisms responsible for the synergistic interactions of the Gulf War-like Exposures lipopolysacharide (LPS) and chlorpyrifos (CPF) (AIM1, Task1); 2) showing potential therapeutic utility in inhibiting NOX2 to attenuate chronic neuroinflammation and neuron damage in response to the GW exposures LPS & CPF (AIM2, Tasks 2 &3); 3) demonstrating the feasibility of the NFκB p50 radical as a peripheral marker for ongoing neuroinflammation and neuropathology in response to the Gulf War exposures LPS and CPF (AIM3, Task 4).
Percentage Completion of Designated Tasks in Year 1
Task 1a 
II. Accomplishments Under the Goals i. Major Activities
Animals Treated: Male mice missing the NF-κB p50 protein and the control strain (C57) were treated with our Multiple-Hit Model of Gulf-War Exposures treatment paradigm: All mice were treated with either LPS (1mg/kg, i.p.) or Saline (i.p.) at 2 months of age. One week after the injection, after the peripheral (but not the central) immune response has been shown to resolve, mice will receive 5 daily injections of either CPF (5mg/kg, s.c.) or peanut oil vehicle (s.c.). The resulting treatment groups were: Saline, LPS, CPF, peanut oil, and CPF + LPS.
Necropsy & Brain Sectioning: Immediate (early -3 hours after last CPF injection) and delayed (chronic -3 months post CPF treatment) animals were euthanized and half of the brain was fixed and sectioned for immunohistochemistry (IHC); half of the brain was be sectioned into the 5 brain regions (olfactory bulb, midbrain, frontal cortex, temporal cortex, and cerebellum) and snap frozen for mRNA and protein analysis.
Preliminary Analysis of Early Time Point Data:
Measures of microglial activation and neuroinflammation at the early 3 h time point was assessed in some samples to confirm success was probable with the experimental design and dose. The full measures of neuroinflammation, oxidative stress, and hippocampal neuropathology will be assessed at both age points to discern the role of NFκB p50 in pathology.
ii. Specific Objectives This task was expected to take the entire first year to complete. 1a. The mouse experiment was expected to take approximately 5 months to complete after receipt of the mice. 1b. Processing and analysis of the samples was predicted to take 7 months. iii.
Significant Results/Key Outcomes
NFκB p50-/-mice are sensitive to chronic neuroinflammation in the hippocampus:
We confirmed with preliminary analysis that at 1 week post LPS injection of the low dose (1mg/kg, IP) only the NFκB p50-/-mice showed chronic neuroinflammation in the hippocampus, confirming vulnerability to lower grade peripheral inflammation.
The samples for AIM 4 are waiting for later processing as expected and the majority of samples for AIM1 are still being processed. The PI's laboratory and the collected samples have moved to IUSM specifically because of the high quality of the animal facilities at IUSM and the ability to support this research. Once the award transfers to IUSM on November 1, 2015, we will process the previously collected samples while simultaneously moving forward here with AIM2 and the second component to AIM4 as originally planned. We believe that the increased productivity due to enhanced facility support with the lab relocation will allow us to close the gap and gain the opportunity to move forward as expected and outlined in the SOW.
Impact
Impact on Science (neuroscience & other disciplines):
The studies in AIM1 are beginning to provide much needed insight into the underlying mechanisms driving why the CNS effects of chemical and pro-inflammatory exposures may persist long after the instigating stimulus, such as what occurs with GWI.
Impact on Technology Transfer
N/A Nothing to Report
Impact on Society -Specifically GW Veterans: In addition, to revealing potential therapeutic targets in AIM1, this work took the first steps of AIM3 that will explore the potential utility of the NFκB p50 protein radical as an early peripheral biomarker of chronic, delayed, and deleterious CNS effects, all of which we believe will provide foundation for future translational GWI studies.
Changes/Problems
I. Changes in Approach
Nothing to report II. Problems, Delays, and Action Plans to Solve Them A. Problems: i. Year 1 -Minor adjustments to vehicle and dose: There were unforeseen minor adjustments necessary due to the unique characteristics of a vehicle and the strain of mouse being tested. We discovered that peanut oil must be used as a vehicle instead of DMSO (DMSO and CPF displayed an unexpected confounding interaction effect on neuroinflammation) and that the LPS dose must be lowered to 1mg/kg IP due to extreme sensitivity of the NFκB p50 -/-mice and unexpected mortality. Solution: These very minor adjustments caused no significant delay and allowed the proposed approach, objectives, and scope of the study to continue as planned.
ii.
Year 1-Animal facility issues: Facility failures led to unexpected termination of ongoing studies and obligated the laboratory to start over on multiple occasions. The setbacks were: 1) Repeated/chronic unannounced renovations in Sanger Hall disturbing chronic studies resulting in both the cessation/loss of ongoing work and stalled initiation of animal studies; 2) There was a November 2013 water main break resulting in loss of both general power and emergency power for 24 hours, where the consequence was the inability work in the building due to chemical hazards from basement flooding and electrical work for 1 month. This terminated ongoing animal research studies and halted bench research for a month. 3) There were several unsuccessful attempts to resolve reoccurring facility issues. Solution: 
